This article explains why Latin America's demographic diversity, cost profile, and accelerating digital health infrastructure make it an ideal region for AI-enabled medical device clinical trials.
Early recognition and mitigation of drug and device integration difficulties are critical to the success of combination products. The collaborative effort in development cannot be overstated.
